Pages

Monday, 14 October 2019

Johnson & Johnson under pressure as FDA approves new use for Xarelto


Johnson & Johnson under pressure as FDA approves new use for Xarelto



Johnson & Johnson shares were flat in trading Monday as legal troubles clouded its financial outlook.

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)